Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients: The ReCap Study

Oncologist - Tập 27 Số 2 - Trang e185-e193 - 2022
Cecilia Margareta Lund1,2, Marta Kramer Mikkelsen3,4, Susann Theile3, Hanne Marie Michelsen3, Martin Schultz1,2, Stéphane Oudard3, Dorte Nielsen5,3
1CopenAge – Copenhagen Center for Clinical Age Research, University of Copenhagen, Copenhagen, Denmark
2Department of Medicine, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark
3Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Copenhagen, Denmark
4Department of Oncology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
5Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark

Tóm tắt

Abstract Background To prevent severe toxicity and hospital admissions, adequate management and recall of information about side effects are crucial and health literacy plays an important role. If age-related factors impact recall of given information and handling of side effects, revised ways to give information are required. Patients and Methods We undertook a questionnaire-based survey among 188 newly diagnosed patients with pancreatic cancer or colorectal cancer and chemo-naive patients with prostate cancer treated with adjuvant or first-line palliative chemotherapy comprising satisfaction with given information, recall of potential side effects, and handling of hypothetical side effect scenarios. We evaluated the association between baseline characteristics, ie, age, frailty (G8 score), comorbidity (Charlson Comorbidity Index), cognitive function (Mini-Cog), satisfaction, recall of information, and handling of side effects. Results Reduced ability to recall information about several side effects (eg, chest pain) was associated with older age (odds ratio adjusted for cancer [aOR] 0.94 [95% CI, 0.88-0.98]) and poor cognitive screening (aOR 0.56 [95% CI, 0.33-0.91]). Insufficient or dangerous handling of side effects was associated with older age (aOR 0.96 (95% CI, 0.92-0.99)) and cognitive impairment (aOR 0.70 [95% CI, 0.50-0.95]). Conclusion Older age and poor cognitive screening may impact patients’ ability to understand and adequately handle chemotherapy-related side effects. Cognitive screening and focus on individual ways to give information including assessment of recall and handling are needed.

Từ khóa


Tài liệu tham khảo

Papadakos, 2018, Health literacy and cancer self-management behaviors: A scoping review., Cancer., 124, 4202, 10.1002/cncr.31733

Siegel, 2020, Cancer statistics, 2020., CA Cancer J Clin, 70, 7, 10.3322/caac.21590

Parry, 2011, Cancer survivors: a booming population., Cancer Epidemiol Biomarkers Prev, 20, 1996, 10.1158/1055-9965.EPI-11-0729

DeSantis, 2014, Cancer treatment and survivorship statistics, 2014., CA Cancer J Clin, 64, 252, 10.3322/caac.21235

Bellizzi, 2008, Cancer survivorship and aging: moving the science forward., Cancer, 113, 3530, 10.1002/cncr.23942

Siegel, 2017, Cancer Statistics, 2017., CA Cancer J Clin, 67, 7, 10.3322/caac.21387

Scher, 2012, Under-representation of older adults in cancer registration trials: known problem, little progress., J Clin Oncol, 30, 2036, 10.1200/JCO.2012.41.6727

Outlaw, 2020, Is the lack of evidence in older adults with cancer compromising safety?, Expert Opin Drug Saf, 19, 1059, 10.1080/14740338.2020.1805429

Hernandez Torres, 2017, Comprehensive geriatric assessment in the older adult with cancer: a review., Eur Urol Focus, 3, 330, 10.1016/j.euf.2017.10.010

Li, 2017, Geriatric assessment and tools for predicting treatment toxicity in older adults with cancer., Cancer J., 23, 206

Wildes, 2013, Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer., J Geriatr Oncol., 4, 227, 10.1016/j.jgo.2013.02.002

Coates, 1983, On the receiving end–patient perception of the side-effects of cancer chemotherapy., Eur J Cancer Clin Oncol., 19, 203, 10.1016/0277-5379(83)90418-2

Pearce, 2017, Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study., PLoS One., 12, e0184360, 10.1371/journal.pone.0184360

Akin, 2010, Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy., Eur J Oncol Nurs., 14, 400, 10.1016/j.ejon.2010.01.003

Lorusso, 2017, Patients’ perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life—an Italian survey., Eur J Cancer Care., 26, 1365, 10.1111/ecc.12618

Mazzotti, 2012, Treatment-related side effects and quality of life in cancer patients., Support Care Cancer., 20, 2553, 10.1007/s00520-011-1354-y

Jansen, 2008, Does age really matter? Recall of information presented to newly referred patients with cancer., J Clin Oncol, 26, 5450, 10.1200/JCO.2007.15.2322

Oken, 1982, Toxicity and response criteria of the Eastern Cooperative Oncology Group., Am J Clin Oncol, 5, 649, 10.1097/00000421-198212000-00014

Charlson, 1994, Validation of a combined comorbidity index., J Clin Epidemiol, 47, 1245, 10.1016/0895-4356(94)90129-5

Arraras, 2010, An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients., Eur J Cancer, 46, 2726, 10.1016/j.ejca.2010.06.118

Bellera, 2012, Screening older cancer patients: first evaluation of the G-8 geriatric screening tool., Ann Oncol, 23, 2166, 10.1093/annonc/mdr587

Decoster, 2015, Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations., Ann Oncol, 26, 288, 10.1093/annonc/mdu210

Winther, 2017, Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9., BMC Cancer, 17, 548, 10.1186/s12885-017-3526-8

Borson, 2003, The Mini-Cog as a screen for dementia: validation in a population-based sample., J Am Geriatr Soc, 51, 1451, 10.1046/j.1532-5415.2003.51465.x

Borson, 2006, Improving identification of cognitive impairment in primary care., Int J Geriatr Psychiat., 21, 349, 10.1002/gps.1470

Tsoi, 2015, Cognitive tests to detect dementia: a systematic review and meta-analysis., JAMA Intern Med., 175, 1450, 10.1001/jamainternmed.2015.2152

Hillen, 2016, Oncologists’ non-verbal behavior and analog patients’ recall of information., Acta Oncol., 55, 671, 10.3109/0284186X.2015.1120884

Nguyen, 2019, Fear and forget: how anxiety impacts information recall in newly diagnosed cancer patients visiting a fast-track clinic., Acta Oncol., 58, 182, 10.1080/0284186X.2018.1512156

Lehmann, 2020, Tailoring the amount of treatment information to cancer patients’ and survivors’ preferences: effects on patient-reported outcomes., Patient Educ Couns., 103, 514, 10.1016/j.pec.2019.09.024

Delgado-Guay, 2013, ‘I don’t want to burden my family’: Handling communication challenges in geriatric oncology., Ann Oncol: Off J Eur Soc Med Oncol/ESMO, 24, vii30, 10.1093/annonc/mdt263

Hurria, 2011, Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study., J Clin Oncol., 29, 3457, 10.1200/JCO.2011.34.7625

Ashida, 2011, Age differences in genetic knowledge, health literacy and causal beliefs for health conditions., Public Health Genom., 14, 307, 10.1159/000316234

Chin, 2017, Cognition and health literacy in older adults’ recall of self-care information., Gerontologist, 57, 261

Mohile, 2018, Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO Guideline for Geriatric Oncology., J Clin Oncol, 36, 2326, 10.1200/JCO.2018.78.8687

Kaiser, 2019, Cognitive performance and psychological distress in breast cancer patients at disease onset., Front Psychol., 10, 2584, 10.3389/fpsyg.2019.02584

Jansen, 2008, Recall in older cancer patients: measuring memory for medical information., Gerontologist., 48, 149, 10.1093/geront/48.2.149

Visovatti, 2016, Assessment of cognitive impairment and complaints in individuals with colorectal cancer., Oncol Nurs Forum., 43, 169, 10.1188/16.ONF.43-02AP

Papanastasiou, 2019, Role of stress, age and adjuvant therapy in the cognitive function of patients with breast cancer., Oncol Lett., 18, 507

Skaali, 2011, Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress., J Psychosom Res., 70, 403, 10.1016/j.jpsychores.2010.12.004

Wagner, 2014, Surgeon-patient communication in oncology., Eur J Cancer Care (Engl)., 23, 585, 10.1111/ecc.12177

Gallo, 2012, Social inequalities and mortality in Europe—results from a large multi-national cohort., PLoS One., 7, e39013, 10.1371/journal.pone.0039013

Woods, 2006, Origins of socio-economic inequalities in cancer survival: a review., Ann Oncol., 17, 5, 10.1093/annonc/mdj007

Williams-Brennan, 2012, Social determinants of health associated with cervical cancer screening among women living in developing countries: a scoping review., Arch Gynecol Obstet., 286, 1487, 10.1007/s00404-012-2575-0

Gast, 2019, Medication adherence influencing factors—an (updated) overview of systematic reviews., Syst Rev., 8, 112, 10.1186/s13643-019-1014-8

Pollock, 2011, Exploring patients’ experience of receiving information about cancer: a comparison of interview and questionnaire methods of data collection., Health (London), 15, 153, 10.1177/1363459309360789